Shihao Li Yi Zhu Zhijian Xu Jianjun Liu Hongwei Liu
10.3389/fonc.2022.866013
Front Oncol
2022 May 10;12:866013.
immunotherapy isolated kidney programmed cell death protein-1 inhibitor tislelizumab urothelial carcinoma
CC BY
https://pubmed.ncbi.nlm.nih.gov/35619897/
Case Reports
PMC9128378
35619897
Isolated Renal Calyceal Urothelial Carcinoma Effectively Treated With PD-1 Inhibitor Alone: A Case Report And Literature Review
2022